J. Agopian

发表

Characterization of S628N: a novel KIT mutation found in a metastatic melanoma.

F. Bertucci, M. Vita, P. Dubreuil, 2014, JAMA dermatology.

SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes

P. Dubreuil, O. Hermine, S. Georgin-lavialle, 2014, Haematologica.

Agricultural pesticide exposure and the molecular connection to lymphomagenesis

B. Nadel, P. Lebailly, Y. Lécluse, 2009, The Journal of experimental medicine.

Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis

B. Nadel, M. Milili, C. Schiff, 2006, The Journal of experimental medicine.

TET2 regulates immune tolerance in chronically activated mast cells

B. Göttgens, O. Bernard, G. Bidaut, 2022, JCI insight.

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

R. Gaillard, J. Kinet, S. Verstovsek, 2017, The Lancet.

Rapid and clinically significant response to masitinib in the treatment of mucosal primary esophageal melanoma with somatic KIT exon 11 mutation involving brain metastases: A case report.

P. Dubreuil, O. Hermine, J. Grim, 2015, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Transplantation in follicular lymphoma: not "yes or no" but "whom and when"

M. Milili, S. Roulland, P. Grenot, 2013 .

Establishing diagnostic criteria for mastocytosis in skin biopsies

P. Dubreuil, O. Hermine, J. Duong van Huyen, 2021, Histopathology.

Absence of severe COVID-19 in patients with clonal mast cells activation disorders: effective anti-SARS-CoV-2 immune response

L. Chatenoud, O. Schwartz, P. Dubreuil, 2021, bioRxiv.

GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness.

A. Órfão, C. Teodosio, J. Asara, 2021, Blood.

Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond.

M. Martín-Martínez, M. Triggiani, A. Órfão, 2022, The journal of allergy and clinical immunology. In practice.

Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis

B. Nadel, M. Milili, C. Schiff, 2006, The Journal of experimental medicine.

Histological characterization of liver involvement in systemic mastocytosis

A. Neuraz, J. Viallard, O. Tournilhac, 2024, Liver international : official journal of the International Association for the Study of the Liver.

A high prevalence of hereditary alpha-tryptasemia in pediatric mastocytoma.

L. Bekel, J. Agopian, P. Dubreuil, 2024, Allergy.

Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study

O. Tournilhac, S. Dimicoli-Salazar, C. Gaudy-Marqueste, 2024, American journal of hematology.

Effective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders

L. Chatenoud, O. Schwartz, P. Dubreuil, 2022, The Journal of Allergy and Clinical Immunology: In Practice.

Criteria for the regression of pediatric mastocytosis: a long-term follow-up.

C. Bodemer, N. Garcelon, A. Neuraz, 2020, The journal of allergy and clinical immunology. In practice.

Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin.

J. Viallard, S. Dimicoli-Salazar, L. Lhermitte, 2024, American journal of hematology.